In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality ...
Objective: To review clinical trials and reports describing the efficacy and safety of atypical antipsychotics (olanzapine, ziprasidone, quetiapine, aripiprazole) in the treatment of autistic or ...
ACADIA Pharmaceuticals Inc (ACAD) reports a 32% annual revenue increase, driven by strong sales of DAYBUE and NUPLAZID, while expanding its pipeline and preparing for European market entry.
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by ...
For teenagers who do not respond to serotonergic medications or CBT, doctors may also consider other types of medication, such as atypical antipsychotics. Researchers have also analyzed the ...
Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.
What I find most exciting about NUPLAZID's sales performance is that we still only have about a 25% market share in those patients receiving atypical antipsychotics for the treatment of Parkinson ...
Talk about a heavy dose. While the bulk of news coverage is focused on GLP-1 drugs like Ozempic that cause weight loss, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results